Example: stock market

Docetaxel

Found 7 free book(s)
For the Patient Docetaxel injection Other names: …

For the Patient Docetaxel injection Other names: …

www.bccancer.bc.ca

For the Patient: Docetaxel injection : Other names: TAXOTERE® Docetaxel (doe-se-TAX-el) is a drug that is used to treat some types of cancer. It is a clear liquid that is injected into a vein. Tell your doctor if you have ever had an unusual or allergic reaction to docetaxel, paclitaxel or cabazitaxel before receiving docetaxel.

  Docetaxel

Baxter Healthcare Corporation DOCETAXEL- …

Baxter Healthcare Corporation DOCETAXEL- …

www.baxterpi.com

DOCETAXEL- docetaxel injection, solution Baxter Healthcare Corporation-----HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use DOCETAXEL INJECTION safely and

  Docetaxel

DRUG NAME: Docetaxel - BC Cancer

DRUG NAME: Docetaxel - BC Cancer

www.bccancer.bc.ca

Docetaxel BC Cancer Agency Cancer Drug Manual© Page 1 of 12 Docetaxel Developed: 1 May 2012 Revised: 1 April 2013, 1 July 2014, 1 January 2015 DRUG NAME: Docetaxel SYNONYM(S): RP56976 COMMON TRADE NAME(S):

  Name, Drug, Drug name, Docetaxel

Data Sheet Docetaxel Ebewe - Medsafe

Data Sheet Docetaxel Ebewe - Medsafe

www.medsafe.govt.nz

Page 1 of 47 Data Sheet Docetaxel Ebewe NAME OF THE MEDICINE Non-proprietary Name Docetaxel Chemical Structure CAS Number 114977-28-5 Chemical name:

  Sheet, Data, Docetaxel, Data sheet docetaxel ebewe, Ebewe

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

www.ema.europa.eu

In combination with trastuzumab the recommended dose of docetaxel is 100 mg/m2 every three weeks, with trastuzumab administered weekly. In the pivotal study the initial docetaxel infusion was started

  Product, Annex, Summary, Annex i summary of product, Docetaxel

ALLEGATO I RIASSUNTO DELLE CARATTERISTICHE …

ALLEGATO I RIASSUNTO DELLE CARATTERISTICHE …

www.ema.europa.eu

5 Adattamento della posologia durante il trattamento: Generale Il docetaxel deve essere somministrato quando la conta dei neutrofili è 1500 cellule/mm3. In pazienti che abbiano manifestato, durante la terapia con docetaxel, neutropenia febbrile, neutrofili

  Docetaxel

Newsletter No.4, 2014 - WHO

Newsletter No.4, 2014 - WHO

www.who.int

Safety of medicines The aim of the Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on communications received

  Newsletter

Similar queries